About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Immuno-Biological Laboratories Co., Ltd.(4570) Summary

4570
TSE Growth
Immuno-Biological Laboratories Co., Ltd.
428
JPY
-23
(-5.10%)
Apr 4, 3:30 pm JST
2.93
USD
Apr 4, 2:30 am EDT
Result
PTS
outside of trading hours
400
Apr 4, 11:43 pm JST
Summary Chart Historical News Financial Result
PER
18.5
PBR
2.85
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 4, 2025
Opening Apr 4, 9:00 am
445 JPY 3.04 USD
Previous Close Apr 3
451 JPY 3.06 USD
High Apr 4, 9:00 am
445 JPY 3.04 USD
Low Apr 4, 1:55 pm
411 JPY 2.82 USD
Volume
159,700
Trading Value
0.07B JPY 0.47M USD
VWAP
426.25 JPY 2.92 USD
Minimum Trading Value
42,800 JPY 293 USD
Market Cap
3.99B JPY 0.03B USD
Number of Trades
324
Liquidity & Number of Trades
As of Apr 4, 2025
Liquidity
Mid
1-Year Average
289
1-Year High Oct 21, 2024
7,902
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 28, 2025 0 624,500
Mar 21, 2025 0 602,500
Mar 14, 2025 0 571,000
Mar 7, 2025 0 622,000
Feb 28, 2025 0 645,000
Company Profile
Immuno-Biological Laboratories Co., Ltd. manufactures and sells research reagents and offers contract services. The silkworm development business has been suspended. The company has entered the cosmetics business.
Sector
Pharmaceuticals
Immuno-Biological Laboratories Co., Ltd. primarily manufactures and sells antibody-based research reagents, in vitro diagnostic pharmaceuticals, and raw materials for in vitro diagnostic pharmaceuticals. The company also develops pharmaceutical seeds utilizing antibody production technology and provides the lipoprotein profiling analysis service "LipoSEARCH". Additionally, the company offers contract services for mass production of proteins and antibodies using genetically modified silkworm technology. Furthermore, in the cosmetics sector, Immuno-Biological Laboratories Co., Ltd. focuses on developing and selling products containing silkworm-derived "NeoSilk-Human Collagen I".